Bracket Global has acquired Boston-based Clintara, which will allow Bracket to integrate the Clintara platform of trial surveillance tools into its electronic platform for Clinical Outcome Assessments (eCOA).
Aeterna Zentaris has selected UK-based Ergomed again for a clinical trial, this time for a confirmatory Phase III study to demonstrate the efficacy of Macrilen (macimorelin), a novel orally-active ghrelin agonist for use in evaluating adult growth hormone deficiency (AGHD).
The Broad Institute of MIT and Harvard is teaming up with Google Genomics to break down technical barriers hindering biomedical research by creating tools to analyze reams of new genomic data.
Swiss CMO Lonza and Canada’s Octane Biotech have entered an exclusive technology evaluation of the Octane Cocoon cell production platform for personalized cell therapy manufacturing with the goal of a global deployment.
Plus senior changes in contract research, and more in Outsourcing-Pharma.com's weekly column.
Contract analytical and bioanalytical service provider SGS Life Science Services has completed construction of its Shanghai, China, cGMP chemistry and biotechnology testing laboratories and will further increase space at its microbiology lab at the site.